CHRISTY OLIPHANT: Open Payments
NPI 1487434726 · CADIZ, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 8 companies in 2025. Trend: 2023 $70 · 2024 $282 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Amgen Inc. | 3 | $51 |
| Novo Nordisk Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Globus Medical, Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: XIFAXAN, Auvelity, Senza, OTEZLA, REPATHA, FARXIGA, Quviviq, MOUNJARO.
Industry payments across KY — which companies pay providers there.
